Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
29,683
-
Share change
-
+3,565
-
Total reported value
-
$2,123,231
-
Price per share
-
$71.63
-
Number of holders
-
11
-
Value change
-
+$254,859
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q2 2025
As of 30 Jun 2025,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,683 shares.
The largest 10 holders included
RHUMBLINE ADVISERS, Sterling Capital Management LLC, S&CO INC, Boston Common Asset Management, LLC, GAMMA Investing LLC, PNC Financial Services Group, Inc., MAR VISTA INVESTMENT PARTNERS LLC, First Horizon Advisors, Inc., Brooklyn Investment Group, and Copeland Capital Management, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.